GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medicover MCOV B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

264.00

-1.12%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medicover

Its shares trade on Nasdaq Stockholm under the ticker MCOV B.ST. It has been listed since 23 May 2017. In the fiscal year to 31 December 2025, it reported revenue of €2.38bn and net income of €77.5m. At that date it held total assets of €2.42bn and shareholders' equity of €532.8m.

Medicover AB engages in the provision of diagnostics with a focus on invitro diagnostics as well as healthcare services. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
23 May 2017
Employees
28,800

Leadership

Pay as last reported

  • Mr. Fredrik StenmoChairman of the Board€121,000
  • Mr. John StubbingtonChief Executive Officer, since 2025
  • Mr. Anand PatelChief Financial Officer
  • Ms. Kamila SkorupinskaChief People Officer
  • Mr. Jaroslaw UrbanczykChief Information Officer
  • Dr. Andrew Vallance-OwenChief Marketing Officer
  • Ms. Jenny BrandtGeneral Legal Counsel
  • Mr. Lukasz KrauseChief Digital Information Officer
  • Mr. Staffan TernstroemChief Operating Officer, Diagnostic Services
  • Mr. Peder af JochnickDirector€56,000
  • Mr. Fredrik RagmarkDirector, since 2025€3.3m
  • Ms. Anne-Catherine BernerIndependent Director€62,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
78
Environment
60
Social
95
Governance
77
Direct emissions (scope 1)
10,620 t
Energy emissions (scope 2)
80,762 t
Value chain emissions (scope 3)
414,186 t
Women in the workforce
71%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medicover AB has several strengths that contribute to its success:

Weaknesses

  • Despite its strengths, Medicover AB also has some weaknesses that it should address:

Opportunities

  • There are several opportunities that Medicover AB can leverage for further growth:

Threats

  • Medicover AB faces various threats that may impact its operations:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.